Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM New Category of Drug-Eluting Stent Approved For U.S. Patients. PR Newswire MARLBOROUGH, Mass. (October 5, 2015) Boston Scientific (NYSE: BSX) has received U.S.

Posted: 2015-10-05 13:03:00

Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.